FIELD: medicine, pulmonology, pharmacy.
SUBSTANCE: invention relates to compositions comprising beta-2-receptor agonist and steroid used in treatment of inflammatory or obstructive diseases of respiratory ways. Medicinal agent comprises a component (A) representing formoterol or its pharmaceutically acceptable salt or formoterol solvate or indicated salt, and a component (B) representing mometasone furoate designated for treatment of inflammatory or obstructive disease of respiratory ways. The composition provides declining doses or mometasone furoate or formoterol significantly that are necessary for providing the specific therapeutic effect as compared with doses required in treatment in using mometasone furoate or formoterol only. This results to minimization of possible undesirable adverse effects.
EFFECT: improved and valuable medicinal properties of agent and set.
15 cl, 281 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS INCLUDING FORMOTEROL AND FLUCTICASON PROPIONATE INDICATED FOR TREATING ASTHMA | 2000 |
|
RU2249454C2 |
| COMPOSITIONS COMPRISING FORMOTEROL AND THIOTROPIUM SALT | 2000 |
|
RU2238085C2 |
| COMBINATION AND PHARMACEUTICAL PREPARATION FOR TREATING INFLAMMATORY AND OBSTRUCTIVE RESPIRATORY DISEASES | 2005 |
|
RU2438660C2 |
| ORGANIC COMPOUNDS | 2001 |
|
RU2292890C2 |
| PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2642624C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING ARFORMOTEROL AND FLUTICASONE FUROATE | 2013 |
|
RU2678992C2 |
| USING FORMOTEROL AND BUDESONIDE-CONTAINING COMPOSITION FOR ACUTE ASTHMA STATE TREATMENT | 1999 |
|
RU2222332C2 |
| AEROSOL COMPOSITION CONTAINIG PHOMOTHEROL | 2000 |
|
RU2327452C2 |
| INHALATION PARTICLES CONTAINING COMBINATION OF ANTICHOLINERGIC, CORTICOSTEROID AND BETA-ADRENERGIC AGENTS | 2015 |
|
RU2697867C2 |
| PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2568882C2 |
